Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-100,000
Closed -$344K 6190
2021
Q2
$344K Sell
100,000
-200,000
-67% -$651K ﹤0.01% 5439
2021
Q1
$822K Buy
+300,000
New +$847K ﹤0.01% 4750
2017
Q1
Sell
-6,400
Closed -$31K 6717
2016
Q4
$31K Hold
6,400
﹤0.01% 6518
2016
Q3
$39K Sell
6,400
-1,600
-20% -$9.56K ﹤0.01% 6555
2016
Q2
$47K Buy
8,000
+7,800
+3,900% +$41.9K ﹤0.01% 6448
2016
Q1
$1K Sell
200
-2,900
-94% -$13.3K ﹤0.01% 7031
2015
Q4
$14K Buy
3,100
+2,600
+520% +$12.7K ﹤0.01% 6918
2015
Q3
$2K Buy
+500
New +$2.71K ﹤0.01% 7234
2015
Q1
Sell
-40,000
Closed -$249K 7043
2014
Q4
$249K Sell
40,000
-12,800
-24% -$80.8K ﹤0.01% 5964
2014
Q3
$346K Buy
52,800
+12,300
+30% +$86.6K ﹤0.01% 5618
2014
Q2
$285K Sell
40,500
-26,100
-39% -$192K ﹤0.01% 5898
2014
Q1
$494K Sell
66,600
-40,900
-38% -$286K ﹤0.01% 5288
2013
Q4
$790K Buy
+107,500
New +$786K ﹤0.01% 4941

Other funds holding ABEV

Goldman Sachs's ABEV Position: Q2 2026 in Review

Goldman Sachs increased its Ambev (ABEV) stake by 79% in Q2 2026, buying an estimated $39.9M and bringing the position to 28,979,606 shares worth $91M. The position accounts for 0.01% of the portfolio, ranked #1288.

Goldman Sachs first reported a position in ABEV in Q4 2013 and has held it in 51 quarters since. The position peaked at $287M in Q3 2022. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Goldman Sachs held 28,979,606 shares of Ambev worth $91M as of Q2 2026.
  • Goldman Sachs bought 12,751,142 Ambev shares in Q2 2026, an estimated $39.9M.
  • Ambev made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1288 holding.
  • Goldman Sachs first reported a position in Ambev in Q4 2013 and has held it in 51 quarters since.
  • Goldman Sachs's Ambev position peaked at $287M in Q3 2022.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.